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Background
The aim of the this study was to analyse if there is an asso-
ciation between angiotensin converting enzyme (ACE)
insertion/deletion (I/D) polymorphism (287 base pairs,
on chromosome 17q23, intron 16 (rs4340)) with asthma
severity. ACE plays a vital role in the renin-angiotensin-
system (RAS) which regulates blood pressure by converting
angiotensin I into a powerful vasoconstrictor angiotensin II,
that also has an important role in airway remodeling and in
inactivation of bradykinin and tachykinins. The signaling
pathways, related with this polymorphism regulating the
cytokine production by T cells, could induce a different Th
profile modulating the immune response in asthma.
Methods
Asthmatic patients: n=68; were compared with a control
group of n=204 healthy blood donors. The insertion/
deletion (I/D) polymorphism was determined by PCR-
polymerase chain reaction. Control of asthma assessed by
validated instrument (ACQ7 and PAQLQ). Statistical
analysis was performed with PASW 18, establishing a sig-
nificance level of p<0.05.
Results
The mean age of the 68 asthmatics was 39.95±18.9
years; 42 females and 26 males; 66 Caucasians and 2
non-Caucasians; 57 atopic and 11 nonatopic. The mean
age of the control-group (n=204) was 40.97±12.08 years;
69 females and 135 males. In asthmatics the frequencies
of the D-Allele (ACE-D) is 0.647 and of the I-Allele
(ACE-I) is 0.353; in controls: 0.868 and 0.132 respec-
tively. There is statistical difference between these groups
(p=0.008). Genotypes in the asthmatics- DD: 44.1%; ID:
20.6%; II: 35,3%; in control group- DD: 48%; ID: 38.8%;
II: 13.2%. There is statistical difference between these
groups (p=0.000). The II genotype was more frequent in
the asthmatics when compared with controls being the
risk associated 3.576 (CI 95% [1.883 – 6.799], (p=0.000).
In asthmatics, there is no statistical differences in geno-
type frequencies (p>0.05) between: atopics and non ato-
pics; controlled and uncontrolled asthma; males and
females; and in the different age-groups.
Conclusions
The role of ACE insertion/deletion (I/D) polymorphism, in
asthmatic patients is a controversy risk factor to the sever-
ity of asthma, but we concluded that the II genotype is
more prevalent in the asthmatics from this hospital-based
population.
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